FILTER
FILTERED INTERVIEW RESULTS
Massimo Scaccabarozzi
PRESIDENT, FARMINDUSTRIA
Farmindustria speaks to GBR about the importance of pharmaceuticals to the Italian economy and society.
Massimiliano Rocchi
SENIOR DIRECTOR ITALY AND GREECE, ACCORD HEALTHCARE ITALIA
Accord Healthcare Italia explains the challenges and opportunities for generics producers in Italy.
Luca Crippa
CEO & MANAGING DIRECTOR, IBSA FARMACEUTICI
Instituto Biochimico, with 2,000 global employees, is attempting to take generics to the next level and continue to expand around the world.
Franco Lori
CEO & FOUNDER, VIROSTATICS
Virostatics is a private drug discovery and development company focused on NCEs used in the treatment of cancers and viral diseases.
Cosimo Lenti
BUSINESS DIRECTOR, DIATHEVA
Diatheva promotes biotechnological innovation by providing high-value customized diagnostic kits and solutions.
Gilda D'Incerti
CEO AND FOUNDER, PQE GROUP
PQE Group explains its imperative to expand rapidly apace with the global life science industry.
Riccardo Palmisano
PRESIDENT, ASSOBIOTEC
Federchimica Assobiotec explains how the association is striving to help Italy’s biotech industry reach the scale that its’ potential offers.
Giovanni Sala
GENERAL MANAGER, MEDAC PHARMA
Medac Pharma explains how producers of original drugs struggle to gain a fair price in Italy.
Enrique Hausermann
PRESIDENT, EGUALIA
Egualia is the Italian association for generics, biosimilars and VMAs and comments on some of the challenges that its’ members face.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
